Aster DM Quality Care Limited Receives Trading Approval for Further Issue of Equity Shares
Aster DM Quality Care Limited, formerly known as Aster DM Healthcare Ltd., has received trading approval for a further issue of equity shares amounting to 35,35,51,410. The approval was secured from both the National Stock Exchange of India Limited (NSE) and the Bombay Stock Exchange (BSE) on August 14, 2026.The company's equity shares, each valued at ₹ 10, were allotted to eligible shareholders of Quality Care India Limited under a Scheme of Amalgamation. The successful receipt of trading approval allows all market participants to trade in these securities starting from Monday, August 17, 2026.
The details regarding the allotted equity shares are as follows:
| Security Description | Symbol | Series | Number of Securities | Distinctive Numbers |
|---|---|---|---|---|
| Equity shares of Rs. 10/- each allotted pursuant to the Scheme of Arrangement | ASTERDM | EQ | 35,355,1410 | 523835315 To 877386724 |
This transaction pertains to the issuance of shares following a Scheme of Amalgamation between Quality Care India Limited (Transferor Company) and Aster DM Healthcare Limited (Transferee Company), which subsequently changed its name to Aster DM Quality Care Limited. The market is informed that these securities will be available for trading from August 17, 2026.
ASTERDM Stock Price Movement
Shares of Aster DM Quality Care Limited slipped by 0.04% on Friday, settling at ₹822.35 after trading closed. The equity experienced notable movement during the session, with a total traded volume of 616,929 shares as it ranged between ₹819.25 and ₹834.3.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.